ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase request List your products (for suppliers)

© 2026 ChemAbout

Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|contact@chemabout.com

Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH (CAS 878797-01-4) | ChemAbout

Home/Compounds/Pharmaceutical Intermediate/Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH

Sourcing Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.84

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH

research compound

SimilarStructure SimilarSimilarity 0.81

Fmoc-Leucine-Serine Pseudoproline

CAS339531-50-9

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.77

(4S)-3-[(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-4-oxazolidinecarboxylic acid

research compound

SimilarStructure SimilarSimilarity 0.77

4-Oxazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4S)-

CAS1000164-43-1

pharmaceutical intermediate

ReferenceSame Category

4-Chloro-2,5-difluorobenzaldehyde

pharmaceutical intermediate

ReferenceSame Category

(R)-tert-Butyl [[piperidin-3-yl]methyl]carbamate

pharmaceutical intermediate

ReferenceSame Category

(R)-3-N-Cbz-aminopyrrolidine

pharmaceutical intermediate

ReferenceSame Category

1-(Propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Sourcing Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

C₃₀H₃₀N₂O₆

514.6 g/mol

Pharmaceutical Intermediate

Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH

CAS878797-01-4

Category

Pharmaceutical Intermediate

Compound Class

Peptide

Primary Use

Pharmaceutical Intermediate

This compound is an Fmoc-protected amino acid derivative used as a building block in solid-phase peptide synthesis. It features a 2,2-dimethyloxazolidine ring system, which provides structural rigidity during peptide assembly.

Fmoc-protected peptide building block for solid-phase peptide synthesisPharmaceutical intermediate for peptide-based drug manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Identifiers

IUPAC Name

(4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid

InChIKey

PQJUKTSKOYOXMZ-UIOOFZCWSA-N

SMILES

CC1(N([C@@H](CO1)C(=O)O)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C

Synonyms (9)

Fmoc-Phe-Ser(|xMe,Mepro)-OH